Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2014

View Archived Issues

TaiGen Biotechnology presents phase III data for oral nemonoxacin

Clinical efficacy and safety of a novel antiretroviral drug for HIV infection

Neurocrine Biosciences begins trial of NBI-98854 in Tourette syndrome

Sorrento Therapeutics outlicenses Chinese rights to anti-PD-L1 antibody

Novartis and BMS collaborate on trials of anticancer immunotherapy combinations

DecImmune Therapeutics awarded SBIR grant to support DeciMab studies

Oryzon Genomics patents novel DDR1 antibodies for cancer

Researchers at Agios Pharmaceuticals patent novel agents for cancer and anemia

Novel agents investigated for fibrosis

Galapagos describes discovery of FFA2 antagonist in development for ulcerative colitis

Actavis and Durata Therapeutics enter merger agreement

Cell Cure Neurosciences files IND with the FDA for OpRegen

New PDE10A inhibitors patented by Merck & Co.

BMS and MD Anderson Cancer Center form immuno-oncology collaboration

Alcobra reports topline results from phase III study of metadoxine in adults with ADHD

Canadian group synthesizes novel PCSK9 inhibitors for LDL-C

Sunesis Pharmaceuticals reports data from pivotal phase III VALOR trial

Chimerix confirms emergency IND application for brincidofovir for Ebola

Capricor Therapeutics to advance CAP-1002 for Duchenne muscular dystrophy

Early clinical results for KRN-23 as potential treatment of X-linked hypophosphatemia

Perosphere signs new trial agreement with Daiichi Sankyo to study PER-977

Medac Pharma launches Rasuvo in U.S.

Acacia Pharma reports phase III data for APD-421 in post-operative nausea and vomiting

FDA expands approval for Eylea Injection in treating macular edema following retinal vein occlusion

Novel selective prostanoid EP2 receptor agonist shows promise in preclinical studies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...